All.Can Patient Survey

All.Can is an international, multi-stakeholder policy initiative aiming to identify ways we can optimise the use of resources in cancer care to improve patient outcomes. All.Can comprises leading representatives from patient organisations, policymakers, healthcare professionals, research and industry, and consists of All.Can international, plus All.Can national initiatives currently established in 13 countries. About All.Can Members of All.Can international are: Matti Aapro , Clinique Genolier, Switzerland; Tit Albreht , Institute of Public Health, Slovenia; Neil Bacon , International Consortium for Health Outcomes Measurement; Kathleen Barnard , Save Your Skin Foundation Canada; Antonella Cardone , European Cancer Patient Coalition (ECPC); Szymon Chrostowski , Polish Cancer Patient Coalition; David Duplay , healtheo360; Alex Filicevas , ECPC; Pascal Garel , HOPE (European Hospital and Healthcare Federation); Stefan Gijssels , Digestive Cancers Europe; Rainer Hess , GVG-Committee on Health Goals; Matthew Hickey , Intacare International Ltd; Petra Hoogendoorn , Goings-On; Vivek Muthu , Marivek Healthcare Consulting; Kathy Oliver , The International Brain Tumour Alliance; Richard Price , European CanCer Organisation; Natalie Richardson , Save Your Skin Foundation Canada; Christobel Saunders , University of Western Australia; Thomas Szucs , University of Basel; Jan van Meerbeeck , Antwerp University Hospital; Lieve Wierinck , Former Member of the European Parliament; Andy Whitman , Varian; Titta Rosvall‑Puplett , Bristol‑Myers Squibb; Karin Steinmann , Amgen; Matthijs Van Meerveld , MSD; Aleksandra Krygiel-Nael , Johnson & Johnson; Shannon Boldon , The Health Policy Partnership (secretariat); Suzanne Wait , The Health Policy Partnership (secretariat) * 02 * Baxter, Helpsy and Roche joined All.Can international in July 2019 (in addition to the members listed here)